Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Non-vitamin K antagonist oral anticoagulants therapy for atrial fibrillation patients undergoing electrophysiologic procedures
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL SUPPLEMENTS
Volume 22, Issue Supplement_I, Pages I32-I37
Publisher
Oxford University Press (OUP)
Online
2020-09-15
DOI
10.1093/eurheartj/suaa102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients
- (2019) Raluca Ileana Mincu et al. Scientific Reports
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial
- (2019) Stefan H Hohnloser et al. EUROPEAN HEART JOURNAL
- Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials
- (2019) William F McIntyre et al. EUROPEAN HEART JOURNAL
- Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant
- (2019) James D. Douketis et al. JAMA Internal Medicine
- Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter
- (2019) Yankun Yang et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Safety and efficacy of non-vitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and meta-analysis
- (2018) Zhen Ge et al. Cardiovascular Therapeutics
- Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
- (2018) Michael D Ezekowitz et al. EUROPEAN HEART JOURNAL
- Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation
- (2018) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
- (2018) Jan Steffel et al. EUROPEAN HEART JOURNAL
- OUP accepted manuscript
- (2018) EUROPEAN HEART JOURNAL
- Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
- (2018) Nelson Telles-Garcia et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Prevalence and Resolution of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation and Flutter With Oral Anticoagulation
- (2018) Adam D Niku et al. AMERICAN JOURNAL OF CARDIOLOGY
- Left Atrial or Left Atrial Appendage Thrombus Resolution After Adjustment of Oral Anticoagulant Treatment
- (2018) Wei-Chieh Lee et al. Journal of Stroke & Cerebrovascular Diseases
- Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin
- (2017) Anne Sofie Frederiksen et al. EUROPACE
- 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary
- (2017) Hugh Calkins et al. EUROPACE
- Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
- (2017) Hugh Calkins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trial
- (2016) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)
- (2016) Gregory Y.H. Lip et al. AMERICAN HEART JOURNAL
- Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study)
- (2016) Toni Grönberg et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48
- (2016) Anna Plitt et al. CLINICAL CARDIOLOGY
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
- (2016) Andreas Goette et al. LANCET
- Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
- (2015) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study
- (2015) Luigi Di Biase et al. HEART RHYTHM
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy
- (2014) Morten Lock Hansen et al. EUROPACE
- Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
- (2014) Riccardo Cappato et al. EUROPEAN HEART JOURNAL
- Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
- (2013) Mohamed Bassiouny et al. Circulation-Arrhythmia and Electrophysiology
- Detection of Left Atrial Appendage Thrombus by Cardiac Computed Tomography in Patients With Atrial Fibrillation
- (2013) Jorge Romero et al. Circulation-Cardiovascular Imaging
- Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
- (2013) David H. Birnie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Left Atrial Catheter Ablation and Ischemic Stroke
- (2011) Karl Georg Haeusler et al. STROKE
- Incidence of left atrial thrombus prior to atrial fibrillation ablation: is pre-procedural transoesophageal echocardiography mandatory?
- (2010) J. W. McCready et al. EUROPACE
- Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
- (2009) Riccardo Cappato et al. Circulation-Arrhythmia and Electrophysiology
- Role of the CHADS2Score in the Evaluation of Thromboembolic Risk in Patients With Atrial Fibrillation Undergoing Transesophageal Echocardiography Before Pulmonary Vein Isolation
- (2009) Sarinya Puwanant et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence and Predictors of Left Atrial Thrombus Prior to Catheter Ablation of Atrial Fibrillation
- (2008) DANIEL SCHERR et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now